Dr. Caspian Oliai
Claim this profileUCLA / Jonsson Comprehensive Cancer Center
Studies Acute Myeloid Leukemia
Studies Leukemia
13 reported clinical trials
18 drugs studied
Area of expertise
1Acute Myeloid Leukemia
HLA-A positive
HLA-A negative
HLA positive
2Leukemia
HLA-A positive
HLA-A negative
HLA positive
Affiliated Hospitals
Clinical Trials Caspian Oliai is currently running
APG-2575 + Azacitidine
for Acute Myeloid Leukemia
This trial is testing a new drug (APG-2575) combined with an existing drug (Azacitidine) to treat certain blood cancers that have not responded to other treatments. The goal is to see if this combination can more effectively kill cancer cells.
Recruiting1 award Phase 1 & 23 criteria
Acalabrutinib Maintenance
for Large B-cell Lymphoma
This phase Ib/II trial studies the side effects and efficacy of maintenance acalabrutinib following cellular therapy in treating patients with large B-cell lymphoma at very high risk of the cancer coming back. Acalabrutinib is a small molecular inhibitor that may interfere with the ability of cancer cells to grow and spread.
Recruiting1 award Phase 1 & 224 criteria
More about Caspian Oliai
Clinical Trial Related3 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Caspian Oliai has experience with
- Azacitidine
- Orca-T
- Liposome-encapsulated Daunorubicin-Cytarabine
- Venetoclax
- Standard-of-Care
- Crenolanib
Breakdown of trials Caspian Oliai has run
Acute Myeloid Leukemia
Leukemia
Myeloid Leukemia
Myelodysplastic Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Caspian Oliai specialize in?
Caspian Oliai focuses on Acute Myeloid Leukemia and Leukemia. In particular, much of their work with Acute Myeloid Leukemia has involved HLA-A positive patients, or patients who are HLA-A negative.
Is Caspian Oliai currently recruiting for clinical trials?
Yes, Caspian Oliai is currently recruiting for 6 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Caspian Oliai has studied deeply?
Yes, Caspian Oliai has studied treatments such as Azacitidine, Orca-T, Liposome-encapsulated Daunorubicin-Cytarabine.
What is the best way to schedule an appointment with Caspian Oliai?
Apply for one of the trials that Caspian Oliai is conducting.
What is the office address of Caspian Oliai?
The office of Caspian Oliai is located at: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California 90095 United States. This is the address for their practice at the UCLA / Jonsson Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.